Part of EVI’s mission, is to address areas of weakness in the infrastructure for vaccine Research and Development, so helping to speed up the development of candidate vaccines for diseases of poverty. In this context, services such as providing access to adjuvants, models, and assays are offered to external partners.

This aspect of EVI's remit includes EVI’s coordination of the European Commission funded translational vaccine project (TRANSVAC).